Regulated Life Sciences Marketing

Less rework.
Faster launches.
Protected margins.

OmniVynt helps life sciences marketing teams and agencies reduce rework, align claims and evidence, improve collaboration, and prepare cleaner assets for formal review.

Advisory-only AIGlass-box logicHuman sign-off retainedPAAB and FDA/OPDP aware
53%Faster internal asset development modelled from 22.75 to 10.75 hours per asset
44%Fewer avoidable resubmission rounds modelled from upstream issue detection
43%Compressed controllable internal cycle time, without replacing formal review

The pressure starts before review

Time is lost when every claim, rule, budget, reference, version, and stakeholder comment has to be checked manually. OmniVynt does much of the heavy organising and checking, while your team keeps review authority and sign-off.

๐Ÿงญ

Claim and evidence control

Keep claims connected to the evidence and source authority that supports them, reducing drift during content development.

๐Ÿค

Better collaboration

Give marketing, agency, medical, regulatory, and legal teams one shared record instead of scattered comments and version confusion.

๐Ÿ“ฆ

Review-ready handoff

Package assets with rationale, references, risk flags, version history, and human decisions before formal review begins.

Check a claim before it becomes rework.

Use the sample scanner to see how OmniVynt surfaces wording risk, evidence gaps, and cleaner alternatives before formal review. Advisory-only. Human reviewers keep final authority.

OmniVynt ยท Claim Intelligence Preview
Enter a commercial claim to analyse
Illustrative preview only. OmniVynt provides advisory analysis, source-aware prompts, and cleaner alternatives. It does not replace MLR, PAAB, PRC, OPDP, legal, medical, or regulatory review.

Less duplicated checking. More controlled execution.

Fewer missed details

Rules, references, claims, and evidence are checked earlier in a repeatable workflow.

Less version chaos

Work moves through controlled states instead of email, shared drives, and manual reconciliation.

Better team confidence

Reviewers see what was checked, what was flagged, and what was approved by humans.

Protected margins

Agencies reduce unpaid rework and can show clients a clearer business case for better process.

OmniVynt strengthens the work before formal review.

The product is not an approval engine and does not replace MLR, PAAB, PRC, legal, or regulatory review. It helps teams prepare better inputs for those processes.

๐Ÿ“ฅ

Content Hub

Centralise asset intake, version state, evidence documents, comments, and campaign context in one structured workspace.

Control
๐Ÿ”—

Evidence Alignment

Connect claims, references, product monographs, label language, TMAs, and clinical sources before wording drifts.

Accuracy
โš ๏ธ

Compliance Intelligence

Surface advisory flags for risky wording, unsupported claims, fair-balance gaps, and reference issues with rationale.

Guardrails
๐Ÿ“ค

Review-Ready Handoff

Export cleaner asset packages with claim rationale, source links, risk notes, and human decisions attached.

Handoff

Different teams. Same avoidable friction.

Agencies

Reduce unpaid rework, version confusion, and margin leakage while giving clients a stronger process story.

Brand and commercial teams

Launch work moves forward with better evidence discipline, clearer approvals, and stronger asset readiness.

Medical, legal, and regulatory

Reviewers see a clearer trail of what was checked, why issues were flagged, and who made the final decision.

Start with real assets, not a generic demo.

Run OmniVynt against actual content, claims, and evidence so your team can see where rework is hiding today.